
Humanized mice bring translationally relevant results with JAX preclinical services
Humanized mice are emerging as essential preclinical in vivo tools to accelerate successful drug development. Their utility lies in their ability to reliably recapitulate human physiology and pathophysiology and predict critical aspects of the human response to immunomodulatory compounds. These models provide drug developers the insights needed to identify problematic compounds and fine-tune lead candidates to confidently advance to the clinic.
In this SelectScience webinar, Dr. Kaya Ghosh, Technical Information Scientist, and Dr. Aaron Rose, senior study director, data analytics and visualization for preclinical services, at The Jackson Laboratory (JAX) share how the company is committed to developing and providing access to humanized mouse models and in vivo drug development services that use humanized mice. Practical examples of humanized mouse model utility and how they are reshaping the biologic drug development pipeline will also be covered.
Key learning objectives
- Learn about genetically and immune humanized mice
- Understand why humanized mice bridge the preclinical-clinical gap better than conventional models
- Discover how JAX’s in vivo Preclinical Research Services can help de-risk drug development and therapeutics into the clinic faster
Certificate of attendance
All webinar participants can request a certificate of attendance, including a learning outcomes summary, for continuing education purposes.
Read more on how humanized mice are reshaping the biologic drug development pipeline >>
Speakers


Moderator


